Canopy Growth Corp. (NASDAQ:CGC) saw a 15.7% surge on Monday due to optimism surrounding potential cannabis rescheduling. President Trump’s administration is considering loosening federal restrictions on cannabis, potentially moving it from Schedule I to Schedule II, which could benefit companies like Canopy and Tilray Brands Inc.

Canopy Growth Corp. (NASDAQ:CGC) is focusing on the US market, anticipating a $50 billion growth in the cannabis industry by next year. While CGC shows promise as an investment, other AI stocks may offer higher returns and lower risks. For more information on a cheap AI stock with potential benefits from Trump’s tariffs, check out our free report.

Read more at Yahoo Finance: Canopy (CGC) Goes 15.7% ‘High’ on Cannabis Rescheduling Optimism